- Home
- COCO vs APGE Comparison
COCO vs APGE Comparison
Compare COCO & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COCO
- APGE
- Stock Information
- Founded
- COCO 2004
- APGE 2022
- Country
- COCO United States
- APGE United States
- Employees
- COCO N/A
- APGE N/A
- Industry
- COCO Beverages (Production/Distribution)
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- COCO Consumer Staples
- APGE Health Care
- Exchange
- COCO Nasdaq
- APGE Nasdaq
- Market Cap
- COCO 1.8B
- APGE 2.1B
- IPO Year
- COCO 2021
- APGE 2023
- Fundamental
- Price
- COCO $35.12
- APGE $41.96
- Analyst Decision
- COCO Buy
- APGE Strong Buy
- Analyst Count
- COCO 7
- APGE 4
- Target Price
- COCO $36.14
- APGE $91.33
- AVG Volume (30 Days)
- COCO 454.4K
- APGE 785.6K
- Earning Date
- COCO 07-30-2025
- APGE 08-11-2025
- Dividend Yield
- COCO N/A
- APGE N/A
- EPS Growth
- COCO 11.36
- APGE N/A
- EPS
- COCO 1.01
- APGE N/A
- Revenue
- COCO $535,236,000.00
- APGE N/A
- Revenue This Year
- COCO $13.81
- APGE N/A
- Revenue Next Year
- COCO $11.17
- APGE $743.14
- P/E Ratio
- COCO $34.86
- APGE N/A
- Revenue Growth
- COCO 8.01
- APGE N/A
- 52 Week Low
- COCO $23.56
- APGE $26.20
- 52 Week High
- COCO $40.32
- APGE $63.50
- Technical
- Relative Strength Index (RSI)
- COCO 54.99
- APGE 56.93
- Support Level
- COCO $32.90
- APGE $40.67
- Resistance Level
- COCO $33.80
- APGE $44.65
- Average True Range (ATR)
- COCO 1.02
- APGE 2.48
- MACD
- COCO 0.01
- APGE 0.18
- Stochastic Oscillator
- COCO 69.13
- APGE 70.41
About COCO The Vita Coco Company Inc.
The Vita Coco Co Inc is a plant-based functional hydration platform. Its products include Vita Coco Coconut Water, Private Label including coconut water and oil, and Other including Runa, Ever & Ever, and PWR LIFT product offerings, Vita Coco product extensions beyond coconut water, such as Vita Coco Sparkling, coconut milk products, and others. The company has two segments: The Americas segment which comprises of operations in the U.S. and Canada; and The International segment that comprises of operations in Europe, the Middle East, Africa and the Asia Pacific regions. The Americas segment derives maximum revenue. Geographical presence of the company is in United States, United Kingdom and All other countries.
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.